>>Description of the research protocol "191622*146"

Observational post-authorisation safety study of VISTABEL® for the treatment of crow’s feet lines (CFL)
Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Dermatologie
Brugmann identifier : 191622*146
EudraCT identifier : B143201731286


Involved department : Dermatology
Principal investigator : Richert
Sponsor : ALLERGAN
Contact : Clinical Research Unit

>This protocol was approved by the UZ Brussel ethics committee.